Why nutrition in early life matters?
Task Force Information
Objectives
The Task Force aims at providing scientific evidence to support guidelines for maternal and infant nutrition to ensure life-time optimal health. It also identifies risk factors for obesity and other health consequences at the earliest stages of life.
Task Force Members
| Janna Van Diepen - Chair | RB Mead Johnson | Principal Scientist | NL |
| Marieke Abrahamse-Berkeveld - Vice-Chair | Danone Nutricia Research | Senior Team Leader Growth & Development | NL |
| Euridice Castaneda Gutierrez | H&H | Science and Communication Manager | CH |
| Susan Ozanne | University of Cambridge | Professor | UK |
| Patricia Iozzo* | Italian National Research Council | Researcher | IT |
| Karen Knipping | Ausnutria | Senior Research Scientist | NL |
| Nils Billecke | Cargill | Senior Nutrition Scientist | BE |
| Marco Turini | DSM - Firmenich | Senior Manager in Nutrition and Health & Wellness | NL |
| Elena Oliveros | Abbott Nutrition | Senior Scientist | ES |
| Carolien van Loo-Bouwman | Yili Innovation Center Europe | Open Innovation Manager | NL |
Contact Information
For more detailed information, please contact Ching-Yu Chang at cchang@ilsieurope.be
Activity Overview
Ongoing
- Early biomarkers for prediction of metabolic health
The Expert Group on early biomarkers for prediction of metabolic health aims to review biomarkers in early life that could be used to predict development of childhood obesity and metabolic health. This prediction may drive knowledge of personalised nutrition.
Start date: May 2021 | End date: Q4 2025
- Lipid quality in early life nutrition
The Expert Group on Lipid quality in early life nutrition aims to generate an overview of the dietary lipid quality in the first year of life and its relations with health benefits for consumers.
Start date: Q3 2022 | End date: Q4 2025
- Plant-based proteins for infants
The Expert Group on Plant-based proteins for infants aims to evaluate the nutritional quality of plant protein-based infant formula for term-born infants (< 1 years old). The group is organising a physical workshop with three sessions: Source, Processing, and Safety; Nutrition Quality and Health Impact; and Sustainability. A proceeding will be published.
Start: Q4 2023 | End: Q4 2025
Upcoming Activities
- Postbiotics for early life nutrition
The Expert Group aims to explore the emerging role of postbiotics in infant nutrition through a focused, workshop-style debate involving experts in microbiota, pediatrics, and nutritional science. This initiative will identify key challenges, assess knowledge gaps, and develop recommendations to guide future research and applications. The outcomes will be published to support evidence-based guidance in infant and early childhood health. This is a joint activity with the Probiotics Task Force.
Start: Q4 2025 | End: Q2 2027
In the Pipeline
- Evidence review on gut-brain-axis, early microbiome development and mental health later in life.
- Evidence review on vegan diet for children.
- Countries nutritional requirements for weaning food (1-3 years) and young child formula.
Expert Groups
Early Biomarkers for Prediction of Metabolic Health
Background and Objectives
The aim of the activity is to review biomarkers in early life that could be used to predict development of childhood obesity and metabolic health. The activity will focus on invasive and non-invasive, perinatal and postnatal biomarkers. This activity aims to:
- Summarise the current evidence for early life (perinatal and postnatal) biomarkers that are able to predict childhood obesity and related metabolic health.
- Emphasise relevance of combining conventional predictive markers (e.g. early weight gain) with novel applications of metabolomics, epigenetics and microbiota profiling. It will help to more accurately and effectively identify infants at risk to develop obesity.
- Emphasise importance of validity and reliability of identified biomarkers for application of such biomarkers in (daily) practice.
Output
The highlighted (recent) findings in the development of biomarkers for early life prediction of metabolic health could be used to guide risk prediction and stratification. This prediction may drive development and knowledge of personalised (infant) nutrition to reduce the risk of childhood obesity. Researchers should become aware of the urgency to develop and validate new predictive biomarkers that are both easily detectable and responsive to nutritional interventions.
Expert Group Members
| Romy Gaillard – Chair | Erasmus University Rotterdam | NL |
| Janna van Diepen – Vice Chair | Reckitt Benckiser/Mead Johnson Nutrition | NL |
| Marieke Abrahamse-Berkeveld | Danone Nutricia Research | NL |
| Sophia Blaauwendraad | Erasmus University Rotterdam | NL |
| Marco Brandimonte-Hernández | University of Granada | ES |
| Maria Carmen Collado | Institute of Agrochemistry and Food Technology | ES |
| Eduard Flores | Institute of Agrochemistry and Food Technology | ES |
| Angel Gil | University of Granada | ES |
| Patricia Iozzo | Italian National Research Council | IT |
| Arwen Kamphuis | Erasmus University Rotterdam | NL |
| Karen Knipping | Ausnutria | NL |
| Francisco Javier Ruiz-Ojeda | University of Granada | ES |
| Kirsten Szklany | Yili Innovation Center Europe | NL |
Lipid Quality in Early Life Nutrition
Background and Objectives
The activity aims to generate an overview of the fatty acid (FA) quality composition consumption (by means of from all dietary sources; human milk, infant milk formula and complementary feeding) in the first year of life and to what extent this brings or relates to its relation to health benefits for infants consumers. A particular focus is given on exploring appropriate intake levels of Saturated Fatty Acids (SFA) and Monounsaturated Fatty Acids (MUFA).
Output
The results will be compiled in a review and published in a peer-reviewed journal. The publication will summarise expert insights and hopefully propose a consensus on the FA profile of the first year of life diet. It will highlight knowledge gaps and outline plans for future research and possibly a basis for new EFSA recommendations.
Expert Group Members
| Francesco Visioli - Chair | University of Padua | IT |
| Nils Billecke - Vice-Chair | Cargill | BE |
| Carlo Agostoni - Scientific Advisor | University of Milan | IT |
| Sebastiano Banni - Scientific Advisor | University of Cagliari | IT |
| Martha Ann Belury - Scientific Advisor | Ohio State University | US |
| Alessandra Mazzocchi | University of Milan | IT |
| Austin Angelotti | Penn State College of Medicine | US |
| Giulia Carla Immacolata Spolidoro | University of Milan | IT |
| Euridice Castaneda Gutierrez | HH | SW |
| Vera Bunt | Ausnutria | NL |
| Valentina Decosmi | University of Milan | IT |
| Marieke Abrahamse | Danone | |
| Carolien Van Loo-Bouwman | Yili Innovation Center | NL |
Plant-based protein for infant
Background and Objectives
The adoption of vegan diets and the consequent demand for plant-based food and plant-based beverages has increased globally, including those suitable for infants. Proteins from plant-based sources usually have lower protein quality and poor technological characteristics (low solubility and poor heat stability) compared to animal-based proteins. Together with the specific infant nutritional requirements, multiple challenges for the application of plant-based proteins are foreseen.
This activity will identify challenges and considerations about the nutritional quality of plant protein-based infant formula for infants below 1 year by organizing a workshop in Q4 2024.
Output
Proceedings of debate/workshop including all challenges, all considerations, gap analysis and guideline for suitability of plant protein-based infant formula.
Expert Group Members
| Kasper Hettinga - Chair | Wageningen University & Research | NL |
| Carolien Van Loo-Bouwman - Vice-Chair | Yili Innovation Center | NL |
| Didier Dupont - Scientific Advisor | INRAE | FR |
| Sascha Verbruggen | Erasmus Medical Center | NL |
| Susan Ozanne | University of Cambridge | UK |
| Elena Oliveros | Abbott | ES |
| Kelly Mulder | Danone Nutricia Research | NL |
Postbiotics for Early Life Nutrition
Background and Objectives
The amount of scientific literature on postbiotics, as well as the term ‘postbiotics’ on commercial products is rapidly rising. This activity aims to advance and discuss specific considerations for the application and development of postbiotics in early life nutrition through a workshop-style debate, resulting in a publication addressing challenges, gap analysis, and recommendations for future research.
Output
The approach for the expert group will be to review the latest state of the art and identify gaps, challenges and potential directions. This should create the basis for a workshop-kind of debate. By leveraging the collective expertise of the commission, the goal is to advance the understanding and application of postbiotics in early life nutrition, ultimately contributing to the development of safer and more effective nutritional products for infants and toddlers. Outcome of this activity is a publication of the proceedings of debate/workshop including existing challenges / gap analysis and guideline for future (clinical) research.
Expert Group Members
| Janna van Diepen | Reckitt / Mead Johnson Nutrition | NL |
| Renaud Mestdagh | DSM-Firmenich | BE |
| Karen Knipping | Ausnutria | NL |
| Kirsten Szklany | Yili Innovation Center Europe | NL |
| Ana Maria Gil Rodriguez | Danone Nutricia Research | NL |
| Benjamin A. H. Jensen | University of Copenhagen | DK |
| Mehreen Anjum | IFF | FI |
| Anja Wellejus | Novonesis | DK |
| Elena Oliveros | Abbott | ES |
| Hania Szajewska | Medical University of Warsaw | PL |
| Simone Guglielmetti | Universita degli Studi di Milano-Bicocca | IT |
| Clara Belzer | Wageningen University & Research | NL |
| Seppo Salminen | University of Turku | FI |
| Karti Korpela | University of Helsinki | FI |
| Sandra Einerhand | Einerhand Science & Innovation | NL |
| Ellen GHM van den Heuvel | LLN NutriResearch | NL |
| Alie de Boer | Maastricht University | NL |
Publications
White Papers/Reports
No results.
Multimedia
Completed Expert Groups
Overview of completed activities since 2021
- Joint nutrition cluster activity on ‘mechanistic insights into the gut-brain axis' in collaboration with Health Benefit Assessment of Foods; Nutrition, Immunity & Inflammation; Nutrition & Brain Health; Prebiotics and Probiotics Task Forces
- Gestational Diabetes and Diet
- Early Bacterial Colonization and Potential Implications Later in Life
- n-3 and n-6 PUFA Intakes, Ratios and Health Effects
- Early Growth Velocity and Risk of Metabolic Disorders Later in Life
- Body Composition in Early Life and Long-Term Health
- Carbohydrates in toddlers’ nutrition
